hemispheric drug strategy cicad/oas

23
Hemispheric Drug Strategy CICAD/OAS October, 2010

Upload: donelle-macadam

Post on 04-Jan-2016

29 views

Category:

Documents


0 download

DESCRIPTION

Hemispheric Drug Strategy CICAD/OAS. October, 2010. Hemispheric Drug Strategy. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Hemispheric Drug Strategy CICAD/OAS

Hemispheric Drug Strategy CICAD/OAS

October, 2010

Page 2: Hemispheric Drug Strategy CICAD/OAS

Hemispheric Drug Strategy• The High Level Group for updating Hemispheric Drug Strategy

completed the process, after carrying out 4 consultative meetings that resulted in the development of 5 drafts and finally in the document presented at the 47th Ordinary Session of CICAD. Likewise, the General Assembly of the Organization of American States at its fortieth regular session in Lima, Peru, June 2010 resolved to endorse the strategy.

• Hemispheric Anti-Drug Strategy leads to the Hemispheric Drug Strategy, which contains a semantic change that means a profound conceptual change as can be seen in the highlights:

Page 3: Hemispheric Drug Strategy CICAD/OAS

• Emphasis on the need to respect human rights in the implementation of Public Policies on Drugs.

• Recognize that poverty and marginalization are elements of vulnerability for the use and trafficking of drugs, and also recognized the need to develop social inclusion policies as a way to mitigate these vulnerabilities.

• Includes the concept of gender in the formulation of public policies on this issue.

• Highlights the importance of institutional strengthening for the development of Public Policies on Drugs.

• Debate highlights the importance of national and hemispheric levels, to promote the participation of the scientific community, policy makers and the community.

• Expressly recognizes that drug dependency is a chronic, relapsing disease with biological, psychological and social and as such should be treated in the field of Public Health.

• Highlights the necessity and importance of Public Policies on Drugs, in all its aspects, be based on scientific evidence.

Hemispheric Drug Strategy

Page 4: Hemispheric Drug Strategy CICAD/OAS

• In the 47 Regular Session of CICAD approved the delegation of Mexico as General Coordinator of the process of developing the Action Plan.

• Also adopted the "Proposed methodology and course of action for the construction of the Plan of Action on Drug Strategy in the Hemisphere."

Plan of action of the Hemispheric Drug Strategy

Page 5: Hemispheric Drug Strategy CICAD/OAS

Plan of action of the Hemispheric Drug Strategy

To facilitate dialogue in the HLG there will be a general coordinator and 5 sub-coordinators by thematic area. Each of the sub-coordinators will work as facilitators of the dialogue: integrating the proposals and actions received by the Member States and identifying the agreeing and disagreeing elements. The general coordinator will be responsible for the development of the proposals consolidated in different thematic areas and will promote consensus among the Member States.

Thematic Areas Coordinator

General coordination Mexico

Institutional Building: Surinam

Demand Reduction: United States

Supply Reduction: Colombia

Control Measures: Argentina

International Cooperation: Venezuela

Page 6: Hemispheric Drug Strategy CICAD/OAS

Building the initial proposal

• Update of the Draft presented before the HLG of the Strategy, based on the Hemispheric Drug Strategy.

• Preparation of an analysis based on the application of a questionnaire, in which the Member States express what they need and can offer in terms of the actions required for the implementation of the Hemispheric Drug Strategy.

Page 7: Hemispheric Drug Strategy CICAD/OAS

Building the initial proposal

Page 8: Hemispheric Drug Strategy CICAD/OAS

• For the development of the Action Plan that allows the implementation of the Hemispheric Drug Strategy, a High Level Group (HLG) is created with the participation of all Member States of CICAD and 23 focal points have been designated to represent them in the process and as far as possible to act as a liaison among the stakeholders in the Member States.

Focal Points

Page 9: Hemispheric Drug Strategy CICAD/OAS

• Virtual Forum: A secure virtual space was created to facilitate this communication. The Group published all the different proposals, support materials and promoted the interaction among the focal points of each Member State, in this virtual space.

• From the initial proposal, it is expected that the Member States will present observations and recommendations, which will be differentiated and separated by thematic area. The coordinators will analyze the different proposals to differentiate and reconcile them. In order to do this, they will interact with those who have made proposals, through the available virtual tools, particularly through the secure virtual forum which will be created.

Dynamic of the Negotiation

Page 10: Hemispheric Drug Strategy CICAD/OAS

• Through the platform we will receiving proposals until October 31st.

• To finalize the electronic consultations a reviewed version of the Action Plan proposal will be developed and distributed to the Member States in preparation for an upcoming in person session.

Dynamic of the Negotiation

Page 11: Hemispheric Drug Strategy CICAD/OAS

• The HLG will meet in person from November 8th to the 11th, in Washington D.C.

Plan of action of the Hemispheric Drug Strategy

Page 12: Hemispheric Drug Strategy CICAD/OAS

How to access the platform?

Page 13: Hemispheric Drug Strategy CICAD/OAS

ENGLISH

Select “English” to read the instructions

Page 14: Hemispheric Drug Strategy CICAD/OAS

Action Plan’s Virtual Communityfor the implementation of the

Hemispheric Drug Strategy

Action Plan’s Virtual Communityfor the implementation of the

Hemispheric Drug Strategy

http://www.cicad.oas.org/community

Page 15: Hemispheric Drug Strategy CICAD/OAS

You must register first in order to access the System.

After registering the first time you can access the System anytime.

The system will automatically send the password to the e-mail address which you had registered.

Page 16: Hemispheric Drug Strategy CICAD/OAS

Argentina

******************

******************

[email protected]

[email protected]

Enter a username

Type a password with at least 8 characters and, must include a symbol or special

character (!@#$%^&*.,)

Type your e-mail address

Select the time zone

Mark the box, if you agree with the terms and conditions.

Select “Join now” to save your information.

RegisterRegister

Page 17: Hemispheric Drug Strategy CICAD/OAS

RegisterRegister

• If your data has been successfully registered, the system will show a welcome message.

• Select CICAD from the toolbar.

Page 18: Hemispheric Drug Strategy CICAD/OAS

RegisterRegister

• For security reasons, all the users must be verified before granted access. The System will show a window to request the access.

• Just left the message box in blank and, select “Request Membership”.

Page 19: Hemispheric Drug Strategy CICAD/OAS

RegisterRegister

• After the username has been verified, you will receive an e-mail confirmation.

Page 20: Hemispheric Drug Strategy CICAD/OAS

LoginLogin

Type your username

Enter your password

Select “Sign In” to access the system.

Page 21: Hemispheric Drug Strategy CICAD/OAS

Bienvenidos al Foro Virtual para la Construcción del Plan de Acción Hemisférico sobre Drogas. Aspiramos a que esta plataforma se constituya en una herramienta central para el intercambio de información con miras a avanzar en el proceso de negociación, a fin de integrar la propuesta de Plan de Acción encomendado por los Comisionados de la CICAD.

Te invitamos a que lo utilices como el medio primordial de comunicación y lo adecues a tus necesidades, ya que su diseño base busca ser una plataforma amigable y flexible que te brinde los elementos necesarios para conducir consultas y formular propuestas.

--- O ---

Welcome to the Virtual Forum for the Construction of the Hemispheric Action Plan on Drugs. We hope that this platform becomes a major tool for exchanging information in order to advance the negotiation process aimed at integrating the Action Plan requested by the Commissioners of the CICAD.

We invite you to use it as the primary means of communication and that you adapt it to suit your needs, since its basic design seeks to be a friendly and flexible platform that gives you the necessary information to conduct consultations and make proposals.

Plan de AcciónEstrategia Hemisférica sobre Drogas

Page 22: Hemispheric Drug Strategy CICAD/OAS

By using this web site, User agrees to the Conditions and Disclaimer set out below:

The General Secretariat of the Organization of American States (“GS/OAS”) maintains this web site for information purposes only. Users may download, copy and reprint information from the site for non-commercial purposes so long as the GS/OAS is cited as the source of the originating material, however, they may not resell, redistribute, or create derivative works absent the express written permission of GS/OAS.

Unless otherwise indicated, the materials published on this web site, including opinions expressed therein, are the responsibility of the individual authors/compilers and not those of the Organization of American States (“OAS”), GS/OAS, and the OAS Member States or its member countries.

This site contains links to web sites not under GS/OAS control. The GS/OAS provides those links as a convenience for users of its site and is not responsible for their contents. The presence of a link does not imply endorsement or approval of its contents by the OAS, GS/OAS, its personnel, or the OAS Member States.

All information on this web site is “as is”. The OAS makes no warranty, express or implied, as to the accuracy or completeness of any of the material on this web site and GS/OAS, its personnel, and OAS are is not liable, jointly, severally, or in any other way, for any expense or damages of any kind incurred as a consequence of its use, including expense or damages arising from communication failure and/or computer malfunctions associated with use of the site. Moreover, GS/OAS, its personnel, and OAS are not liable for any actions taken in reliance on or otherwise based upon the information on this web site.

As a condition of use of this web site, the User agrees to indemnify GS/OAS, OAS, and OAS organs from and against any and all actions, law suits, damages and expenses, including court costs and legal fees, arising out of User’s use of this web site and the information herein contained.

If User is dissatisfied with the information on this web site, User’s sole and exclusive remedy is to cease using it.

User acknowledges that all Forums and discussion groups are public and not private communications. Users of the online forums pages contained on this site may not engage in any illegal or defamatory practices and are bound by the agreements described therein. The OAS reserves the right to remove at any time and without notice material sent to such forums. In using or otherwise participating in those Forums (including chat rooms and discussion groups), User agrees:

Terms and Conditions

a) not to defame, abuse, harass, stalk, threaten or otherwise violate the legal rights of others;

b) not to publish, distribute or disseminate any defamatory, infringing, obscene, indecent or unlawful material or information;

c) not to upload or attach files that contain viruses, corrupted files, software that may damage the operation of another’s hardware, and material protected by intellectual property laws without first obtaining the permission of the intellectual property rights holder;

d) not delete any author attributions, legal notices, or labels in any file uploaded;e) not falsify the origin or source of software in uploaded material;f) not advertise or sell any goods or services or conduct or forward surveys, contests or

chain letters, or download any file that User knows or reasonably should know cannot be legally distributed by such method.

GS/OAS at its sole discretion, may, without notice and for any reason whatsoever:

a) remove any and all content of the Forums, regardless of its origin, andb) deny any user access to this web site. c) Use of this web site will result in the storage of certain information about User on

GS/OAS’ server, including, but not limited to, internet protocol (IP), navigation through the site, items purchased, credit card information submitted by User, software used, and time spent, user’s address, and user’s name if provided. The primary purpose of this information is to help GS/OAS make the site more responsive to Users and particularly those who are repeat Users. GS/OAS, its personnel, and OAS assume no responsibility for the security of that information. Users who elect the option of registering on the site will have a “cookie” created on their hard drive to facilitate user management of subscriptions and the user’s online profile.

d) Nothing in these Conditions and Disclaimer constitutes a waiver of the privileges and immunities of OAS, GS/OAS, or its personnel.

http://www.oas.org/en/terms_conditions.asp

Page 23: Hemispheric Drug Strategy CICAD/OAS

Thank you.

Organization of American StatesInter-American Drug Abuse Control Commission

1889 F Street, N.W.Washington, DC 20006

Phone. 202.458.3179 Fax. 202.458.3658